Arya Mariam Roy

643 total citations
74 papers, 355 citations indexed

About

Arya Mariam Roy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Arya Mariam Roy has authored 74 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Arya Mariam Roy's work include Cancer Immunotherapy and Biomarkers (15 papers), Breast Cancer Treatment Studies (12 papers) and HER2/EGFR in Cancer Research (8 papers). Arya Mariam Roy is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Breast Cancer Treatment Studies (12 papers) and HER2/EGFR in Cancer Research (8 papers). Arya Mariam Roy collaborates with scholars based in United States, Japan and India. Arya Mariam Roy's co-authors include Renuka Iyer, Sayan Chakraborty, Shipra Gandhi, Kazuaki Takabe, Kristopher Attwood, Masanori Oshi, Yoshihisa Tokumaru, Rongrong Wu, Saby George and Itaru Endo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Arya Mariam Roy

62 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arya Mariam Roy United States 10 170 114 87 79 38 74 355
Lennart Lenk Germany 12 233 1.4× 151 1.3× 39 0.4× 87 1.1× 42 1.1× 20 415
Yukinori Ozaki Japan 11 295 1.7× 62 0.5× 102 1.2× 66 0.8× 21 0.6× 51 385
Tristan Maurina France 10 108 0.6× 118 1.0× 154 1.8× 73 0.9× 17 0.4× 30 293
Nuria Rodrı́guez-Salas Spain 13 307 1.8× 140 1.2× 99 1.1× 114 1.4× 12 0.3× 32 485
Vincent Verschaeve Belgium 9 112 0.7× 157 1.4× 147 1.7× 59 0.7× 22 0.6× 21 389
Kristen K. Ciombor United States 10 191 1.1× 84 0.7× 78 0.9× 62 0.8× 7 0.2× 26 315
Qirong Geng China 12 112 0.7× 172 1.5× 158 1.8× 117 1.5× 32 0.8× 27 469
Jérôme Alexandre France 3 139 0.8× 296 2.6× 174 2.0× 78 1.0× 30 0.8× 4 445
Lee Gorden United States 8 205 1.2× 127 1.1× 55 0.6× 154 1.9× 17 0.4× 11 407
Jana Halámková Czechia 10 191 1.1× 191 1.7× 108 1.2× 206 2.6× 20 0.5× 36 553

Countries citing papers authored by Arya Mariam Roy

Since Specialization
Citations

This map shows the geographic impact of Arya Mariam Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arya Mariam Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arya Mariam Roy more than expected).

Fields of papers citing papers by Arya Mariam Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arya Mariam Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arya Mariam Roy. The network helps show where Arya Mariam Roy may publish in the future.

Co-authorship network of co-authors of Arya Mariam Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Arya Mariam Roy. A scholar is included among the top collaborators of Arya Mariam Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arya Mariam Roy. Arya Mariam Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Roy, Arya Mariam, Ankita Kapoor, Kristopher Attwood, et al.. (2024). Real-world efficacy and adverse events of neoadjuvant immunotherapy in patients with early-stage triple-negative breast cancer: A multi-center experience.. Journal of Clinical Oncology. 42(16_suppl). e23293–e23293.
3.
Roy, Arya Mariam, Paola Zagami, Kristopher Attwood, et al.. (2024). Real-World Clinical Outcomes With Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer. JCO Oncology Practice. 21(5). 620–628. 7 indexed citations
4.
5.
Roy, Arya Mariam, et al.. (2024). Abstract PO3-06-10: Real World Outcomes with Sacituzumab Govitecan in Metastatic Triple Negative Breast Cancer Patients: A Multi-Institution Study. Cancer Research. 84(9_Supplement). PO3–6. 1 indexed citations
6.
7.
Öztürk, Cemile Nurdan, Kohei Chida, Arya Mariam Roy, et al.. (2024). Updates on Breast Reconstruction: Surgical Techniques, Challenges, and Future Directions. World Journal of Oncology. 15(6). 853–870. 2 indexed citations
8.
Amisha, Fnu, et al.. (2023). A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers. SHILAP Revista de lepidopterología. 3(2). 96–124. 9 indexed citations
9.
Roy, Arya Mariam, et al.. (2023). A review of treatment options in HER2‐low breast cancer and proposed treatment sequencing algorithm. Cancer. 129(18). 2773–2788. 10 indexed citations
10.
Oshi, Masanori, Arya Mariam Roy, Osamu Matsuura, et al.. (2023). E2F target score is associated with cell proliferation and survival of patients with hepatocellular carcinoma. Surgery. 174(2). 307–314. 13 indexed citations
11.
Roy, Arya Mariam & Saby George. (2023). Emerging resistance vs. losing response to immune check point inhibitors in renal cell carcinoma: two differing phenomena. Cancer Drug Resistance. 6(3). 642–55. 7 indexed citations
12.
Roy, Arya Mariam, et al.. (2023). Predictors of Complete Pathological Response with Chemoimmunotherapy in Triple-Negative Breast Cancer: A Meta-Analysis. SHILAP Revista de lepidopterología. 4(1). 1–14. 1 indexed citations
13.
Gupta, Kush, Kristopher Attwood, Ashish Gupta, et al.. (2023). Association between Environmental Temperature and Survival in Gastroesophageal Cancers: A Population Based Study. Cancers. 16(1). 74–74. 3 indexed citations
14.
Roy, Arya Mariam, et al.. (2023). Pembrolizumab (Pem) in metastatic castration-resistant prostate cancer (mCRPC): Experience from a comprehensive cancer center.. Journal of Clinical Oncology. 41(6_suppl). 113–113.
15.
Deshmukh, Ashish A., et al.. (2023). Prevalence of obstructive airway disease in pulmonary function tests of patients visiting respiratory medicine out patient department. International Journal of Research in Medical Sciences. 11(3). 941–946. 1 indexed citations
16.
Roy, Arya Mariam, et al.. (2023). Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage Breast Cancer. JAMA Network Open. 6(11). e2344517–e2344517. 8 indexed citations
17.
Gosain, Rohit, et al.. (2022). Health-Related Quality of Life (HRQoL) in Neuroendocrine Tumors: A Systematic Review. Cancers. 14(6). 1428–1428. 13 indexed citations
18.
Roy, Arya Mariam, Ashish Gupta, Kazuaki Takabe, et al.. (2022). Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?. Cancers. 14(8). 1856–1856. 17 indexed citations
19.
Mohan, Meera, Samantha Kendrick, Anikó Szabó, et al.. (2021). Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma. Blood Advances. 6(3). 808–817. 18 indexed citations
20.
Thomas, Vinay Mathew, et al.. (2020). 1608P Publication rate and characteristics of cancer clinical trials in India. Annals of Oncology. 31. S968–S968. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lennart Lenk Breakdown of academic impact, for papers by Yukinori Ozaki Breakdown of academic impact, for papers by Tristan Maurina Breakdown of academic impact, for papers by Nuria Rodrı́guez-Salas Breakdown of academic impact, for papers by Vincent Verschaeve Breakdown of academic impact, for papers by Kristen K. Ciombor Breakdown of academic impact, for papers by Qirong Geng Breakdown of academic impact, for papers by Jérôme Alexandre Breakdown of academic impact, for papers by Lee Gorden Breakdown of academic impact, for papers by Jana Halámková
Rankless by CCL
2026